D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
TSHA holding history
Taysha Gene Therapies, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TSHA overviewAll 13F holders of TSHAFull Q2 2026 holdings
- Shares (Q2 2026)
- 4,398,652
- Value
- $30.0M
- % of portfolio
- <0.1%
- Quarters held
- 9
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 4,398,652 | $30.0M | <0.1% | −28,649−0.6% | Reduced | Holders |
| Q1 2026 | 4,427,301 | $19.8M | <0.1% | +413,666+10.3% | Added | Holders |
| Q4 2025 | 4,013,635 | $22.1M | <0.1% | +1,307,201+48.3% | Added | Holders |
| Q3 2025 | 2,706,434 | $8.85M | <0.1% | +2,304,925+574.1% | Added | Holders |
| Q2 2025 | 401,509 | $927.5K | <0.1% | +401,509 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −107,274−100.0% | Sold out | Holders |
| Q3 2022 | 107,274 | $207.0K | <0.1% | −27,311−20.3% | Reduced | Holders |
| Q2 2022 | 134,585 | $501.0K | <0.1% | +59,851+80.1% | Added | Holders |
| Q1 2022 | 74,734 | $487.0K | <0.1% | +74,734 | New | Holders |
| Q3 2021 | 0 | $0 | 0.0% | −11,448−100.0% | Sold out | Holders |
| Q2 2021 | 11,448 | $243.0K | <0.1% | +11,448 | New | Holders |